Randomized cross-over study of mirabegron and vibegron in female overactive bladder

Randomized cross-over study of mirabegron and vibegron in female overactive bladder - Comparative study in mirabegron and vibegron

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000034720

Enrollment

100

Registered

2018-12-01

Start date

2019-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

overactive bladder

Interventions

Vibegron Mirabegron

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Female OAB patients with less than 150ml of postvoid residual

Exclusion criteria

Exclusion criteria: Patients who have severe liver and heart dysfucntion

Design outcomes

Primary

Measure	Time frame
Improvement of OABSS	—

Countries

Japan

Contacts

Public ContactNaoki Wada

Asahikawa Medical University Department of Renal and Urologic Surgery

nwada@asahikawa-med.ac.jp0166-68-2533

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026